Melanoma News and Research

Latest Melanoma News and Research

Pain Therapeutics modifies strategic alliance with King Pharmaceuticals for REMOXY outside U.S.

Pain Therapeutics modifies strategic alliance with King Pharmaceuticals for REMOXY outside U.S.

Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers

Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers

Anti-inflammatory interventions may protect sensitive skin types from sunburn

Anti-inflammatory interventions may protect sensitive skin types from sunburn

Oxsoralen-Ultra therapy for severe psoriasis now available in the U.S. on a limited supply basis

Oxsoralen-Ultra therapy for severe psoriasis now available in the U.S. on a limited supply basis

Folic acid and vitamin B12 lower homocysteine levels in patients who experience heart attack: JAMA

Folic acid and vitamin B12 lower homocysteine levels in patients who experience heart attack: JAMA

Michigan State University researchers analyze histiocytic sarcomas

Michigan State University researchers analyze histiocytic sarcomas

Pfizer to discontinue commercial availability of Mylotarg for AML in U.S.

Pfizer to discontinue commercial availability of Mylotarg for AML in U.S.

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

Exelixis announces regaining of rights to develop and commercialize XL184

Exelixis announces regaining of rights to develop and commercialize XL184

Prototype drug blocks MCL-1 protein that helps tumors survive treatment: Scientists

Prototype drug blocks MCL-1 protein that helps tumors survive treatment: Scientists

Neupro improves wellbeing impaired by pain related to Restless Legs Syndrome

Neupro improves wellbeing impaired by pain related to Restless Legs Syndrome

Protect Your Lungs, LUNGevity Foundation announce merger

Protect Your Lungs, LUNGevity Foundation announce merger

VCU researchers discover mechanism that regulates gene expression and growth in melanoma cells

VCU researchers discover mechanism that regulates gene expression and growth in melanoma cells

RG7204 holds promise for metastatic melanoma with V600E BRAF mutation

RG7204 holds promise for metastatic melanoma with V600E BRAF mutation

Identification of key player in signaling pathway offers hope for new targeted melanoma therapies

Identification of key player in signaling pathway offers hope for new targeted melanoma therapies

Independent SMB recommends continuance of Allovectin-7 Phase 3 trial for metastatic melanoma

Independent SMB recommends continuance of Allovectin-7 Phase 3 trial for metastatic melanoma

Study validates Grm1 protein as target for melanoma treatment

Study validates Grm1 protein as target for melanoma treatment

Combination of BRAF-targeted therapy and immunotherapy shows promise for treatment of melanoma

Combination of BRAF-targeted therapy and immunotherapy shows promise for treatment of melanoma

First patient treated in multicentre Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine for melanoma

First patient treated in multicentre Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine for melanoma

Study: Millions of cancer survivors put off care they can't afford

Study: Millions of cancer survivors put off care they can't afford

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.